Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Aug 30;9(8):e029819.
doi: 10.1136/bmjopen-2019-029819.

The global epidemiology of viral-induced acute liver failure: a systematic review protocol

Jenna Patterson  1   2 , Hannah Sophia Hussey  3   2 , Leila Hussein Abdullahi  2   4 , Sheetal Silal  5   6   7 , Liz Goddard  8 , Mashiko Setshedi  9 , Wendy Spearman  10 , Gregory D Hussey  3   11 , Benjamin Kagina  3   2 , Rudzani Muloiwa  3   12
Affiliations

The global epidemiology of viral-induced acute liver failure: a systematic review protocol

Jenna Patterson et al. BMJ Open. .

Abstract

Introduction: The burden of viral-induced acute liver failure (ALF) around the world still remains unclear, with little to no data collected regarding the disease incidence in general and synthesised data on the relative contribution of different viruses to the aetiology of ALF is missing in the field. The aim of this review is to estimate the burden (prevalence, incidence, mortality, hospitalisation) of ALF following infection HAV, HBV, HCV, HDV, HEV, EBV), HSV1, HSV2, VZV, parvo-virus B19, HPIVs, YFV, HVV-6, CMV, CA16 and/or HAdVs. Establishing the common aetiologies of viral-induced ALF, which vary geographically, is important so that: (1) treatment can be initiated quickly, (2) contraindications to liver transplant can be identified, (3) prognoses can be deterined more accurately, and most importantly, (4) vaccination against viral ALF aetiologies can be prioritised especially in under-resourced regions with public health risks associated with the relevant attributable diseases.

Methods and analysis: EBSCOhost, PubMed, ScienceDirect, Scopus and Web of Science databases will be searched for relevant literature published and grey literature from 2009 up to 2019. Published cross-sectional and cohort studies will be eligible for inclusion in this review. Qualifying studies will be formally assessed for quality and risk of bias using a standardised scoring tool. Following standardised data extraction, meta-analyses will be carried out using STATA. Depending on characteristics of included studies, subgroup analyses and meta-regression analyses will be performed. This review will be reported according to Preferred Reporting Items for Systematic reviews and Meta-Analyses guidelines.

Ethics and dissemination: No ethics approval is required as the systematic review will use only published data already in the public domain. Findings will be disseminated through publication in a peer-reviewed journal.

Prospero registration number: CRD42018110309.

Keywords: acute liver failure; epidemiology; global.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

References

    1. Lee WM, Stravitz RT, Larson AM. Introduction to the revised American association for the study of liver diseases position paper on acute liver failure 2011. Hepatology 2012;55:965–7. 10.1002/hep.25551 - DOI - PMC - PubMed
    1. Wendon, J, Cordoba J, Dhawan A, et al. EASL clinical practical guidelines on the management of acute (fulminant) liver failure. J Hepatol 2017;66:1047–81. 10.1016/j.jhep.2016.12.003 - DOI - PubMed
    1. O'Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet 1993;342:273–5. 10.1016/0140-6736(93)91818-7 - DOI - PubMed
    1. Morabito V, Adebayo D. Fulminant hepatitis: definitions, causes and management. Health 2014;06:1038–48. 10.4236/health.2014.610130 - DOI
    1. O'Grady JG, failure Aliver. Acute liver failure. Postgrad Med J 2005;81:148–54. 10.1136/pgmj.2004.026005 - DOI - PMC - PubMed

Publication types